The Parkinson’s Foundation published a new article in the December issue of The Joint Commission Journal on Quality and Patient Safety titled “Protecting Parkinson’s Patients: Hospital Care Standards to Avoid Preventable Harm.” The article identifies sustainable solutions to improve care in the hospital for people with Parkinson’s disease (PD) and details how these solutions may be generalized to develop a practical, disease-agnostic care model for all hospital and health systems that wish to avoid preventable harm.
… Full Story>Archives for November 2024
Dr. Gilbert Hosts: Dental Challenges and Parkinson’s Disease, November 21, 2:30pm PT
The mouth is rarely considered in the care of Parkinson’s Disease (PD), even though PD can cause several mouth-related issues. On November 21 Dr. Gilbert will have an in-depth discussion about dental challenges and PD with Board-Certified Dentist Anesthesiologist Louis Seigelman, DDS. Dr. Seigelman specializes in dental care for patients with unique medical situations, such as PD.
… Full Story>WAPO – Make this one lifestyle change to lower your Parkinson’s disease risk
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
… Full Story>Dr. Jocelyn Jiao to speak on palliative care – November 19, 2024
Please join Stanford movement disorder specialist and palliative care physician Jocelyn Jiao at the CurePSP virtual care conference on Tuesday, November 19, 10:35am-11:25am PT. She will provide an overview of palliative care and how it can help with symptom management.
… Full Story>Webinar Notes: Understanding Progressive Supranuclear Palsy (PSP)
On August 6 PMD Alliance hosted a webinar on Understanding Supranuclear Palsy (PSP). PSP is a neurodegenerative disease that can mimic Parkinson’s, but PSP is a distinct diagnosis with its own features and treatments. Amazingly, there are seven subtypes of PSP!
Movement disorders specialist, David Shprecher, DO, gave an overview of symptoms, the diagnostic process, complications of PSP, as well as current treatment options and the importance of participating in clinical trials (including brain donation) to advance understanding of PSP and develop new treatment options.